Skip to main content

Animations

MJFF Publications

5721 - 5730 of 9156 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2020
  • 2024
  • 2022
  • Summary Details
    OPEN
    Title: Global cellular proteo-lipidomic profiling of diverse lysosomal storage disease mutants using nMOST
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adu5787
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2024/5580870
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Changes in Oxidised Phospholipids in Response to Oxidative Stress in Microtubule-Associated Protein Tau (MAPT) Mutant Dopamine Neurons
    Journal Name: Antioxidants
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/antiox13050508
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s0140-6736(24)00685-8
    Citation Count: 953
  • Summary Details
    OPEN
    Title: Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00719-w
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-63130-8
    Citation Count: 19
  • Summary Details
    OPEN
    Title: [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease
    Journal Name: Neurology International
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/neurolint16020031
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2020.02.034
    Citation Count: 259
  • Summary Details
    OPEN
    Title: [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00221-024-06815-w
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18‐Year Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29221
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.